Medline ® Abstract for Reference 39
of 'The ketogenic diet and other dietary therapies for the treatment of epilepsy'
39
TI
New GLUT-1 mutation in a child with treatment-resistant epilepsy.
AU
Slaughter L, Vartzelis G, Arthur T
SO
Epilepsy Res. 2009;84(2-3):254.
Mutations in the human glucose transporter type I (GLUT-1) gene may result in a phenotype of epilepsy, developmental delay, and movement abnormalities. We present a previously unreported mutation, c.1454 C>T (pPro485Leu) as a likely cause of intractable infantile-onset epilepsy and mild developmental delay in an 11-year-old girl. CSF:serum glucose ratio was 45%. She has had clinical improvement on a modified Atkins diet. Our patient helps further refine the phenotype of Glut-1 deficiency and reveals a new pathologic mutation.
AD
Child Neurology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229, United States. laurel.malinowski@cchmc.org
PMID